IMaging pilot study of the avß6 integrin radiotracer [18F]A20FMDV2 in PAtients with solid Cancer Types

Trial Profile

IMaging pilot study of the avß6 integrin radiotracer [18F]A20FMDV2 in PAtients with solid Cancer Types

Recruiting
Phase of Trial: Phase I

Latest Information Update: 17 Jun 2016

At a glance

  • Drugs GSK 2634673F (Primary)
  • Indications Breast cancer; Head and neck cancer; Pancreatic cancer; Solid tumours
  • Focus Diagnostic use
  • Most Recent Events

    • 11 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top